# Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation

> **NCT00717379** · PHASE4 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 50 (actual)

## Conditions studied

- Kidney Transplantation
- Kidney Failure, Chronic
- Renal Insufficiency, Chronic

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** Mycophenolate Mofetil
- **DRUG:** Methylprednisolone or equivalent
- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT00717379
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2009-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00717379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00717379, "Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00717379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*